Skip to main content
Erschienen in: Current Hepatology Reports 1/2020

20.02.2020 | Nutrition in Patients with Chronic Liver Disease (E Tapper, Section Editor)

The Role of Nutrition in the Pathogenesis and Treatment of Alcohol-Related Liver Disease

verfasst von: Haripriya Maddur, Vijay H. Shah

Erschienen in: Current Hepatology Reports | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Abstract

Abstract

Malnutrition is increasingly being recognized as a poor prognostic factor in the realm of chronic liver disease, particularly among those individuals with end-stage liver disease undergoing transplant evaluation.

Purpose of Review

The purpose of this review is to demonstrate how nutrition contributes to disease pathogenesis and whether improvements in nutrition can alter disease pathogenesis.

Recent Findings

Recent findings reveal that the role of nutrition is multifaceted, primarily due to alterations in gut microbiota and cytokine release. Additionally, there is increasing data demonstrating that those with gastric bypass are more susceptible to developing end-stage liver disease with lesser amounts of alcohol use.

Summary

The role of nutrition as relates to liver disease is complex and involves not only global calorie replacement but also management of micronutrient deficiencies. Future research should focus on further tools to assess for malnutrition and prevention of sarcopenia.
Literatur
1.
Zurück zum Zitat Antonow DR McClain CJ. Nutrition and alcoholism. Alcohol and the Brain 1985:pp. 81–120. Antonow DR McClain CJ. Nutrition and alcoholism. Alcohol and the Brain 1985:pp. 81–120.
2.
Zurück zum Zitat Guthrie GD, Myers KJ, Gesser EJ, White GW, Koehl JR. Alcohol as a nutrient: interactions between ethanol and carbohydrate. Alcohol Clin Exp Res. 1990;14:17–22.CrossRef Guthrie GD, Myers KJ, Gesser EJ, White GW, Koehl JR. Alcohol as a nutrient: interactions between ethanol and carbohydrate. Alcohol Clin Exp Res. 1990;14:17–22.CrossRef
3.
Zurück zum Zitat Lin HZ, Yang SQ, Zeldin G, Diehl AM. Chronic ethanol consumption induces the production of tumor necrosis factor-alpha and related cytokines in liver and adipose tissue. Alcohol Clin Exp Res. 1998;22:231S–7S.CrossRef Lin HZ, Yang SQ, Zeldin G, Diehl AM. Chronic ethanol consumption induces the production of tumor necrosis factor-alpha and related cytokines in liver and adipose tissue. Alcohol Clin Exp Res. 1998;22:231S–7S.CrossRef
4.
Zurück zum Zitat Campillo B, Sherman E, Richardet JP, Bories PN. Serum leptin levels in alcoholic liver cirrhosis: relationship with gender, nutritional status, liver function and energy metabolism. Eur J Clin Nutr. 2001;55:980–8.CrossRef Campillo B, Sherman E, Richardet JP, Bories PN. Serum leptin levels in alcoholic liver cirrhosis: relationship with gender, nutritional status, liver function and energy metabolism. Eur J Clin Nutr. 2001;55:980–8.CrossRef
5.
Zurück zum Zitat Thursz MR, Richardson P, Allison M, et al. Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med. 2015;372:1619–28.CrossRef Thursz MR, Richardson P, Allison M, et al. Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med. 2015;372:1619–28.CrossRef
6.
Zurück zum Zitat •• Moreno C, Deltenre P, Senterre C, et al. Intensive enteral nutrition is ineffective for patients with severe alcoholic hepatitis treated with corticosteroids. Gastroenterology. 2016;150:903–10 e8. This reference is important because it refuted nutrition replacement alone as a therapy for severe alcoholic hepatitis. CrossRef •• Moreno C, Deltenre P, Senterre C, et al. Intensive enteral nutrition is ineffective for patients with severe alcoholic hepatitis treated with corticosteroids. Gastroenterology. 2016;150:903–10 e8. This reference is important because it refuted nutrition replacement alone as a therapy for severe alcoholic hepatitis. CrossRef
7.
Zurück zum Zitat •• Kirpich IA, Petrosino J, Ajami N, et al. Saturated and unsaturated dietary fats differentially modulate ethanol-induced changes in gut microbiome and metabolome in a mouse model of alcoholic liver disease. Am J Pathol. 2016;186:765–76. This reference is relevant due to the revelation that not all nutrients provide benefit. CrossRef •• Kirpich IA, Petrosino J, Ajami N, et al. Saturated and unsaturated dietary fats differentially modulate ethanol-induced changes in gut microbiome and metabolome in a mouse model of alcoholic liver disease. Am J Pathol. 2016;186:765–76. This reference is relevant due to the revelation that not all nutrients provide benefit. CrossRef
8.
Zurück zum Zitat •• Song M, Chen T, Prough RA, Cave MC, McClain CJ. Chronic alcohol consumption causes liver injury in high-fructose-fed male mice through enhanced hepatic inflammatory response. Alcohol Clin Exp Res. 2016;40:518–28. This reference is relevant due to a plausible explanation for alcohol liver disease and non-alcohol-related liver disease overlap. CrossRef •• Song M, Chen T, Prough RA, Cave MC, McClain CJ. Chronic alcohol consumption causes liver injury in high-fructose-fed male mice through enhanced hepatic inflammatory response. Alcohol Clin Exp Res. 2016;40:518–28. This reference is relevant due to a plausible explanation for alcohol liver disease and non-alcohol-related liver disease overlap. CrossRef
9.
Zurück zum Zitat • Hartmann P, Hochrath K, Horvath A, et al. Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice. Hepatology. 2018;67:2150–66. This reference is relevant due to a revelation of mechanism of action. CrossRef • Hartmann P, Hochrath K, Horvath A, et al. Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice. Hepatology. 2018;67:2150–66. This reference is relevant due to a revelation of mechanism of action. CrossRef
10.
Zurück zum Zitat Mutlu E, Keshavarzian A, Engen P, Forsyth CB, Sikaroodi M, Gillevet P. Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats. Alcohol Clin Exp Res. 2009;33:1836–46.CrossRef Mutlu E, Keshavarzian A, Engen P, Forsyth CB, Sikaroodi M, Gillevet P. Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats. Alcohol Clin Exp Res. 2009;33:1836–46.CrossRef
11.
Zurück zum Zitat Chen YL, Yang SS, Peng HC, Hsieh YC, Chen JR, Yang SC. Folate and vitamin B12 improved alcohol-induced hyperhomocysteinemia in rats. Nutrition. 2011;27:1034–9.CrossRef Chen YL, Yang SS, Peng HC, Hsieh YC, Chen JR, Yang SC. Folate and vitamin B12 improved alcohol-induced hyperhomocysteinemia in rats. Nutrition. 2011;27:1034–9.CrossRef
12.
Zurück zum Zitat Leo MA, Lieber CS. Alcohol, vitamin A, and beta-carotene: adverse interactions, including hepatotoxicity and carcinogenicity. Am J Clin Nutr. 1999;69:1071–85.CrossRef Leo MA, Lieber CS. Alcohol, vitamin A, and beta-carotene: adverse interactions, including hepatotoxicity and carcinogenicity. Am J Clin Nutr. 1999;69:1071–85.CrossRef
13.
Zurück zum Zitat Hanje AJ, Fortune B, Song M, Hill D, McClain C. The use of selected nutrition supplements and complementary and alternative medicine in liver disease. Nutr Clin Pract. 2006;21:255–72.CrossRef Hanje AJ, Fortune B, Song M, Hill D, McClain C. The use of selected nutrition supplements and complementary and alternative medicine in liver disease. Nutr Clin Pract. 2006;21:255–72.CrossRef
14.
Zurück zum Zitat Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010;362:1675–85.CrossRef Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010;362:1675–85.CrossRef
15.
Zurück zum Zitat Mezey E, Potter JJ, Rennie-Tankersley L, Caballeria J, Pares A. A randomized placebo controlled trial of vitamin E for alcoholic hepatitis. J Hepatol. 2004;40:40–6.CrossRef Mezey E, Potter JJ, Rennie-Tankersley L, Caballeria J, Pares A. A randomized placebo controlled trial of vitamin E for alcoholic hepatitis. J Hepatol. 2004;40:40–6.CrossRef
16.
Zurück zum Zitat Ghorbani Z, Hajizadeh M, Hekmatdoost A. Dietary supplementation in patients with alcoholic liver disease: a review on current evidence. Hepatobiliary Pancreat Dis Int. 2016;15:348–60.CrossRef Ghorbani Z, Hajizadeh M, Hekmatdoost A. Dietary supplementation in patients with alcoholic liver disease: a review on current evidence. Hepatobiliary Pancreat Dis Int. 2016;15:348–60.CrossRef
17.
Zurück zum Zitat Mohammad MD, Falker KC, Song M, et al. Low dose zinc sulfate (220 mg) supplementation for three months normalizes zinc levels, endotoxemia, pro-inflammatory biomarkers and improves clinical parameters in alcoholic cirrhosis- a double blind placebo controlled- (ZAC) clinical trial. Hepatology 2015; 62:851A Mohammad MD, Falker KC, Song M, et al. Low dose zinc sulfate (220 mg) supplementation for three months normalizes zinc levels, endotoxemia, pro-inflammatory biomarkers and improves clinical parameters in alcoholic cirrhosis- a double blind placebo controlled- (ZAC) clinical trial. Hepatology 2015; 62:851A
18.
Zurück zum Zitat •• Nishikawa H, Enomoto H, Yoh K, et al. Serum Zinc Concentration and Sarcopenia: A Close Linkage in Chronic Liver Diseases. J Clin Med. 2019;11:8(3). This reference outlines the role of micronutrients and sarcopenia. •• Nishikawa H, Enomoto H, Yoh K, et al. Serum Zinc Concentration and Sarcopenia: A Close Linkage in Chronic Liver Diseases. J Clin Med. 2019;11:8(3). This reference outlines the role of micronutrients and sarcopenia.
21.
Zurück zum Zitat • Kalafateli M, Mantzoukis K, Choi Yau Y, et al. Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of the model for end-stage liver disease score. J Cachexia Sarcopenia Muscle. 2017;8:113–21. This reference highlights the impact of malnutrition as relates to transplant. CrossRef • Kalafateli M, Mantzoukis K, Choi Yau Y, et al. Malnutrition and sarcopenia predict post-liver transplantation outcomes independently of the model for end-stage liver disease score. J Cachexia Sarcopenia Muscle. 2017;8:113–21. This reference highlights the impact of malnutrition as relates to transplant. CrossRef
22.
Zurück zum Zitat Sinclair M, Gow PJ, Grossmann M, Angus PW. Review article: sarcopenia in cirrhosis--aetiology, implications and potential therapeutic interventions. Aliment Pharmacol Ther. 2016;43:765–77.CrossRef Sinclair M, Gow PJ, Grossmann M, Angus PW. Review article: sarcopenia in cirrhosis--aetiology, implications and potential therapeutic interventions. Aliment Pharmacol Ther. 2016;43:765–77.CrossRef
23.
Zurück zum Zitat Dasarathy J, McCullough AJ, Dasarathy S. Sarcopenia in alcoholic liver disease: clinical and molecular advances. Alcohol Clin Exp Res. 2017;41:1419–31.CrossRef Dasarathy J, McCullough AJ, Dasarathy S. Sarcopenia in alcoholic liver disease: clinical and molecular advances. Alcohol Clin Exp Res. 2017;41:1419–31.CrossRef
24.
Zurück zum Zitat Cuellar RE, Tarter R, Hays A, Van Thiel DH. The possible occurrence of “alcoholic hepatitis” in a patient with bulimia in the absence of diagnosable alcoholism. Hepatology. 1987;7:878–83.CrossRef Cuellar RE, Tarter R, Hays A, Van Thiel DH. The possible occurrence of “alcoholic hepatitis” in a patient with bulimia in the absence of diagnosable alcoholism. Hepatology. 1987;7:878–83.CrossRef
25.
Zurück zum Zitat Platis IE, Carpenter LL, Vojvoda D, Bowers MB Jr, Mazure CM. Possible acceleration of alcoholic cirrhosis in a patient with bulimia. Int J Eat Disord. 1996;20:439–42.CrossRef Platis IE, Carpenter LL, Vojvoda D, Bowers MB Jr, Mazure CM. Possible acceleration of alcoholic cirrhosis in a patient with bulimia. Int J Eat Disord. 1996;20:439–42.CrossRef
26.
Zurück zum Zitat Vidot H, Kline K, Cheng R, et al. The Relationship of Obesity, Nutritional Status and Muscle Wasting in Patients Assessed for Liver Transplantation. Nutrients. 2019;4:11(9) Vidot H, Kline K, Cheng R, et al. The Relationship of Obesity, Nutritional Status and Muscle Wasting in Patients Assessed for Liver Transplantation. Nutrients. 2019;4:11(9)
27.
Zurück zum Zitat •• Cherla DV, Rodriguez NA, Vangoitsenhoven R. Impact of sleeve gastrectomy and Roux-en_y gastric bypass on biopsy-proven non-alcoholic fatty liver disease. Surg Endosc. 2019;29. This reference highlights recent observations in patients with gastric bypass being susceptible to alcohol-related liver disease. •• Cherla DV, Rodriguez NA, Vangoitsenhoven R. Impact of sleeve gastrectomy and Roux-en_y gastric bypass on biopsy-proven non-alcoholic fatty liver disease. Surg Endosc. 2019;29. This reference highlights recent observations in patients with gastric bypass being susceptible to alcohol-related liver disease.
28.
Zurück zum Zitat •• Garg SK SS, Bazerbachi F, et al. Bariatric surgery is associated with increased risk of alcoholic hepatitis: analysis from National Inpatient Database. Presented at AASLD, 2018, San Francisco, CA 2018. This reference highlights recent observations in patients with gastric bypass being susceptible to alcohol-related liver disease. •• Garg SK SS, Bazerbachi F, et al. Bariatric surgery is associated with increased risk of alcoholic hepatitis: analysis from National Inpatient Database. Presented at AASLD, 2018, San Francisco, CA 2018. This reference highlights recent observations in patients with gastric bypass being susceptible to alcohol-related liver disease.
29.
Zurück zum Zitat Sharma R, Gentry RT, Lim RT Jr, Lieber CS. First-pass metabolism of alcohol. Absence of diurnal variation and its inhibition by cimetidine after evening meal. Dig Dis Sci. 1995;40:2091–7.CrossRef Sharma R, Gentry RT, Lim RT Jr, Lieber CS. First-pass metabolism of alcohol. Absence of diurnal variation and its inhibition by cimetidine after evening meal. Dig Dis Sci. 1995;40:2091–7.CrossRef
30.
Zurück zum Zitat Klockhoff H, Naslund I, Jones AW. Faster absorption of ethanol and higher peak concentration in women after gastric bypass surgery. Br J Clin Pharmacol. 2002;54:587–91.CrossRef Klockhoff H, Naslund I, Jones AW. Faster absorption of ethanol and higher peak concentration in women after gastric bypass surgery. Br J Clin Pharmacol. 2002;54:587–91.CrossRef
31.
Zurück zum Zitat Ivezaj V, Stoeckel LE, Avena NM, Benoit SC, Conason A, Davis JF, et al. Obesity and addiction: can a complication of surgery help us understand the connection? Obes Rev. 2017;18:765–75.CrossRef Ivezaj V, Stoeckel LE, Avena NM, Benoit SC, Conason A, Davis JF, et al. Obesity and addiction: can a complication of surgery help us understand the connection? Obes Rev. 2017;18:765–75.CrossRef
32.
Zurück zum Zitat Cabre E, Rodriguez-Iglesias P, Caballeria J, et al. Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial. Hepatology. 2000;32:36–42.CrossRef Cabre E, Rodriguez-Iglesias P, Caballeria J, et al. Short- and long-term outcome of severe alcohol-induced hepatitis treated with steroids or enteral nutrition: a multicenter randomized trial. Hepatology. 2000;32:36–42.CrossRef
33.
Zurück zum Zitat Mendenhall CLAS, Weesner RE, et al. Protein-calorie malnutrition associated with alcoholic hepatitis. Veterans administration cooperative study group on alcoholic hepatitis. Am J Med. 1984;76:211–22.CrossRef Mendenhall CLAS, Weesner RE, et al. Protein-calorie malnutrition associated with alcoholic hepatitis. Veterans administration cooperative study group on alcoholic hepatitis. Am J Med. 1984;76:211–22.CrossRef
34.
Zurück zum Zitat Singal AK, Kamath PS, Francisco Ziller N, DiCecco S, Shoreibah M, Kremers W, et al. Nutritional status of patients with alcoholic cirrhosis undergoing liver transplantation: time trends and impact on survival. Transpl Int. 2013;26:788–94.CrossRef Singal AK, Kamath PS, Francisco Ziller N, DiCecco S, Shoreibah M, Kremers W, et al. Nutritional status of patients with alcoholic cirrhosis undergoing liver transplantation: time trends and impact on survival. Transpl Int. 2013;26:788–94.CrossRef
35.
Zurück zum Zitat Huynh DK, Selvanderan SP, Harley HA, Holloway RH, Nguyen NQ. Nutritional care in hospitalized patients with chronic liver disease. World J Gastroenterol. 2015;21:12835–42.CrossRef Huynh DK, Selvanderan SP, Harley HA, Holloway RH, Nguyen NQ. Nutritional care in hospitalized patients with chronic liver disease. World J Gastroenterol. 2015;21:12835–42.CrossRef
36.
Zurück zum Zitat Plauth M, Cabre E, Riggio O, et al. ESPEN guidelines on enteral nutrition: liver disease. Clin Nutr. 2006;25:285–94.CrossRef Plauth M, Cabre E, Riggio O, et al. ESPEN guidelines on enteral nutrition: liver disease. Clin Nutr. 2006;25:285–94.CrossRef
37.
Zurück zum Zitat Morgan MY, Madden AM, Soulsby CT, Morris RW. Derivation and validation of a new global method for assessing nutritional status in patients with cirrhosis. Hepatology. 2006;44:823–35.CrossRef Morgan MY, Madden AM, Soulsby CT, Morris RW. Derivation and validation of a new global method for assessing nutritional status in patients with cirrhosis. Hepatology. 2006;44:823–35.CrossRef
38.
Zurück zum Zitat Alvares-da-Silva MR, Reverbel da Silveira T. Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients. Nutrition. 2005;21:113–7.CrossRef Alvares-da-Silva MR, Reverbel da Silveira T. Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients. Nutrition. 2005;21:113–7.CrossRef
39.
Zurück zum Zitat Plauth M, Bernal W, Dasarathy S, Merli M, Plank LD, Schütz T, et al. ESPEN guideline on clinical nutrition in liver disease. Clin Nutr. 2019;38:485–521.CrossRef Plauth M, Bernal W, Dasarathy S, Merli M, Plank LD, Schütz T, et al. ESPEN guideline on clinical nutrition in liver disease. Clin Nutr. 2019;38:485–521.CrossRef
Metadaten
Titel
The Role of Nutrition in the Pathogenesis and Treatment of Alcohol-Related Liver Disease
verfasst von
Haripriya Maddur
Vijay H. Shah
Publikationsdatum
20.02.2020
Verlag
Springer US
Erschienen in
Current Hepatology Reports / Ausgabe 1/2020
Elektronische ISSN: 2195-9595
DOI
https://doi.org/10.1007/s11901-020-00504-2

Weitere Artikel der Ausgabe 1/2020

Current Hepatology Reports 1/2020 Zur Ausgabe

Portal Hypertension and Liver Transplantation (R Reddy, Section Editor)

Recurrent Disease After Liver Transplantation

Nutrition in Patients with Chronic Liver Disease (E Tapper, Section Editor)

Food as Therapy for Frailty

Nutrition in Patients with Chronic Liver Disease (E Tapper, Section Editor)

Nutrition in Cholestatic Liver Disease

Nutrition in Patients with Chronic Liver Disease (E Tapper, Section Editor)

What Diet Should I Recommend My Patient with Hepatic Encephalopathy?

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.